These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 27091549)

  • 1. Reduced fibrillar β-amyloid in subcortical structures in a butyrylcholinesterase-knockout Alzheimer disease mouse model.
    Darvesh S; Reid GA
    Chem Biol Interact; 2016 Nov; 259(Pt B):307-312. PubMed ID: 27091549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Butyrylcholinesterase-knockout reduces fibrillar β-amyloid and conserves
    DeBay DR; Reid GA; Macdonald IR; Mawko G; Burrell S; Martin E; Bowen CV; Darvesh S
    Brain Res; 2017 Sep; 1671():102-110. PubMed ID: 28729192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Butyrylcholinesterase-knockout reduces brain deposition of fibrillar β-amyloid in an Alzheimer mouse model.
    Reid GA; Darvesh S
    Neuroscience; 2015 Jul; 298():424-35. PubMed ID: 25931333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of Exogenous Butyrylcholinesterase with β-Amyloid Plaques in 5XFAD/Butyrylcholinesterase-Knockout Mouse Brain.
    Reid GA; Darvesh S
    Curr Alzheimer Res; 2021; 18(6):470-481. PubMed ID: 34455970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of exogenous acetylcholinesterase and butyrylcholinesterase with amyloid-β plaques in human brain tissue.
    Reid GA; Darvesh S
    Chem Biol Interact; 2024 May; 395():111012. PubMed ID: 38648920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Butyrylcholinesterase as a Diagnostic and Therapeutic Target for Alzheimer's Disease.
    Darvesh S
    Curr Alzheimer Res; 2016; 13(10):1173-7. PubMed ID: 27040140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of Butyrylcholinesterase Activity as a Sensitive and Specific Biomarker of Alzheimer's Disease.
    Macdonald IR; Maxwell SP; Reid GA; Cash MK; DeBay DR; Darvesh S
    J Alzheimers Dis; 2017; 58(2):491-505. PubMed ID: 28453492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal evaluation of a novel BChE PET tracer as an early
    Rejc L; Gómez-Vallejo V; Joya A; Moreno O; Egimendia A; Castellnou P; Ríos-Anglada X; Cossío U; Baz Z; Passannante R; Tobalina-Larrea I; Ramos-Cabrer P; Giralt A; Sastre M; Capetillo-Zarate E; Košak U; Knez D; Gobec S; Marder M; Martin A; Llop J
    Theranostics; 2021; 11(13):6542-6559. PubMed ID: 33995675
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunohistochemical analysis of hippocampal butyrylcholinesterase: Implications for regional vulnerability in Alzheimer's disease.
    Mizukami K; Akatsu H; Abrahamson EE; Mi Z; Ikonomovic MD
    Neuropathology; 2016 Apr; 36(2):135-45. PubMed ID: 26293308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Butyrylcholinesterase radioligands to image Alzheimer's disease brain.
    Darvesh S
    Chem Biol Interact; 2013 Mar; 203(1):354-7. PubMed ID: 22935510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurological cholinesterases in the normal brain and in Alzheimer's disease: relationship to plaques, tangles, and patterns of selective vulnerability.
    Wright CI; Geula C; Mesulam MM
    Ann Neurol; 1993 Sep; 34(3):373-84. PubMed ID: 8363355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity of butyrylcholinesterase knockout mice to (--)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission.
    Duysen EG; Li B; Darvesh S; Lockridge O
    Toxicology; 2007 Apr; 233(1-3):60-9. PubMed ID: 17194517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electron microscopic localization of cholinesterase activity in Alzheimer brain tissue.
    Carson KA; Geula C; Mesulam MM
    Brain Res; 1991 Feb; 540(1-2):204-8. PubMed ID: 2054612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholinesterases in normal and Alzheimer's disease primary olfactory gyrus.
    Hamodat H; Cash MK; Fisk JD; Darvesh S
    Neuropathol Appl Neurobiol; 2017 Dec; 43(7):571-583. PubMed ID: 28644906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Butyrylcholinesterase in the life cycle of amyloid plaques.
    Guillozet AL; Smiley JF; Mash DC; Mesulam MM
    Ann Neurol; 1997 Dec; 42(6):909-18. PubMed ID: 9403484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTK2B/Pyk2 overexpression improves a mouse model of Alzheimer's disease.
    Giralt A; de Pins B; Cifuentes-Díaz C; López-Molina L; Farah AT; Tible M; Deramecourt V; Arold ST; Ginés S; Hugon J; Girault JA
    Exp Neurol; 2018 Sep; 307():62-73. PubMed ID: 29803828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and Preliminary Evaluation of Phenyl 4-123I-Iodophenylcarbamate for Visualization of Cholinesterases Associated with Alzheimer Disease Pathology.
    Macdonald IR; Reid GA; Pottie IR; Martin E; Darvesh S
    J Nucl Med; 2016 Feb; 57(2):297-302. PubMed ID: 26541777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropathology and cholinesterase expression in the brains of octogenarians and older.
    Maxwell SP; Cash MK; Darvesh S
    Chem Biol Interact; 2022 Sep; 364():110065. PubMed ID: 35872043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-dependent association between butyrylcholinesterase K-variant and Alzheimer disease-related neuropathology in human brains.
    Ghebremedhin E; Thal DR; Schultz C; Braak H
    Neurosci Lett; 2002 Mar; 320(1-2):25-8. PubMed ID: 11849755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential laminar distribution of acetylcholinesterase and butyrylcholinesterase containing tangles in the cerebral cortex of Alzheimer's disease.
    Coleman AE; Geula C; Price BH; Mesulam MM
    Brain Res; 1992 Nov; 596(1-2):340-4. PubMed ID: 1467998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.